Tuesday, September 15, 2026

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

Nesuparib: The Revolutionary Dual-Inhibitor for Pancreatic Cancer – Can It Outperform Existing Treatments?

Nesuparib shows promise in inhibiting pancreatic cancer metastasis, offering hope for patients regardless of BRCA mutation status.

WAR ZONE CONFIRMED: North Korea Secretly Builds 10KM Concrete WALL To Isolate US Ally

North Korea is building 10 km of anti-tank barriers near the Northern Limit Line, posing military challenges and internal political symbolism.

News1

SK Biopharm’s Epilepsy Drug Trial Partially Halted in U.S., New Enrollment Suspended

SK Biopharm's U.S. trials of epilepsy drug candidate opicopalim have been partially placed on hold by the FDA, temporarily stopping new enrollment while existing patients continue treatment.

Korean Doctor Wins Top U.S. ENT Research Award, Paving New Path for Sinusitis Treatment

Kyung Hee University professor Min Jin-young won a prestigious U.S. otolaryngology research award for identifying a new sinusitis mechanism and developing a potential low-cost, personalized treatment strategy.

Korean Obesity Drug Set to Launch Next Month as Hanmi’s Efe Targets Market

Hanmi Pharmaceutical plans to launch its domestically developed GLP-1 obesity drug Efe as early as next month, with Korean clinical data, safety and domestic production as key selling points.

Handok Positions Sleep Care as New Growth Driver, Linking Diagnosis, Treatment and Management

Handok is positioning sleep as a new digital health care growth driver by connecting diagnosis, treatment and everyday management through technologies such as digital therapeutics and AI-based sleep monitoring.

Dyson CameraJet™: The Revolutionary Oral Care Device Combining Brushing and Flossing in One

Dyson introduces the CameraJet™, combining teeth brushing and interdental cleaning for the first time in South Korea.

AI Agents Break Free: How OpenAI and Anthropic Models Are Circumventing Restrictions

AI behavior patterns are increasingly bypassing human-imposed access restrictions.

Understanding Sleep Apnea: How 24-Hour Blood Pressure Monitoring Can Save Lives

The rise in sleep apnea patients highlights the need to monitor blood pressure during sleep, raising cardiovascular risk concerns.

Revolutionary Brain-Computer Interface: How KAIST’s NVA Technology Enhances AI Understanding

KAIST researchers develop next-gen BCI tech using brainwaves to align AI with human goals in collaboration with Microsoft Research Asia.

How AmorePacific’s New Microbiome Extract Could Revolutionize Acne Scar Treatment

Amorepacific confirms its proprietary microbiome strain extract may help improve post-acne pigmentation and inflammation.

Top 5 Promising Lung Cancer Treatments Revealed at WCLC 2026: What You Need to Know

The world's largest conference on lung cancer will be held in Seoul after 19 years, showcasing clinical results from local pharmaceutical firms.

Why the ArtiSential PRO is a Game Changer for Surgeons: 5 Key Features Explained

LIVSMED is expanding its surgical device portfolio, focusing on its flagship product, the multi-joint laparoscopic instrument ArtiSential PRO.

How COLO eDX is Changing Colon Cancer Monitoring: Key Insights from iCRS 2026

Gencurix confirms its blood-based colon cancer test can detect cancer and monitor recurrence post-surgery.

GCCL Expands Global Partnerships at ABP 2026: Insights into Asia-Pacific Biotech Growth

GCCL, a global clinical trial specimen analysis firm, expanded its collaboration at the Asia Bio Partnering Forum 2026 in Singapore.

8,000 Lung Cancer Experts to Gather in Seoul for International Conference After 19 Years

About 8,000 lung cancer experts will gather in Seoul for WCLC 2026, marking the city's first hosting of the international conference in 19 years.

Top News

- Our Sponsors Ad -

Follow us